Matters of legal in nature including licensing, intellectual property, and lawsuits.
EDEN PRAIRIE, Minn., May 20, 2019 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems, motion simulators and sensors, today announced the commissioning of an MTS Flat-Trac Handling Roadway at FKFS, a globally renowned automotive research and development institute. FKFS will deploy the roadway to enable faster evaluation of vehicle... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed another patent infringement suit against one of BGI Group’s subsidiaries, BGI Europe A/S. Illumina filed suit in the Maritime & Commercial High Court of Denmark. “As we have previously stated, Illumina will continue to vigorously protect our patented technology and file patent suits... Read more
Basel, 08 May 2019 Roche to present new OCREVUS (ocrelizumab) data analyses showing significant reduction of disability progression in relapsing and primary progressive multiple sclerosis at the AAN Annual Meeting New analyses show the effect of OCREVUS on reducing the risk of disability progression is associated with exposure and lower B-cell levels Long-term data in... Read more
CHELMSFORD, Mass., May 7, 2019 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in three upcoming investor conferences: Bank of America Merrill Lynch Health Care Conference at the Encore Hotel in Las Vegas, Nevada on May 16, 2019 at 8:00 a.m. PDT (11:00 a.m. EDT). UBS Global Healthcare Conference at... Read more
Basel, 07 May 2019 Roche presents data from the risdiplam pivotal FIREFISH and SUNFISH studies in spinal muscular atrophy at the 2019 AAN Annual Meeting In the dose-finding Part 1 of FIREFISH, infants with Type 1 spinal muscular atrophy survive and achieve key milestones beyond those expected in the natural history of the disease New... Read more
2019/05/07 Kusatsu/Shiga, Japan – April 24, 2019 – Takara Bio Inc. (Takara Bio) announced that Takara Biotechnology (Dalian) Co., Ltd. (Dalian city, China, hereafter “Takara Biotechnology (Dalian)”), a wholly-owned subsidiary of Takara Bio has acquired ISO 13485:2016 certification, an international standard for quality management system of medical devices and diagnostic pharmaceuticals. Takara Biotechnology (Dalian) is a... Read more
Nottingham, UK – 24th April 2019 – BioCity, a pioneering life science incubator and business collective, today announced investment in Deep Branch Biotechnology, a Nottingham-based carbon recycling start-up, developing technology that transforms polluters into producers. Unlike traditional carbon storage technology that simply collects and stores carbon dioxide, Deep Branch’s carbon recycling solution converts carbon dioxide... Read more
Date: 04/08/2019 HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Bio-Rad’s IH-500, an automated random access system for blood typing and screening. The IH-500 system was designed for small-... Read more
Date: 04/02/2019 HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has received U.S. Food and Drug Administration (FDA) clearance for its BioPlex 2200 Lyme Total Assay, an innovative multiplex test method to aid in the diagnosis of Lyme disease. Lyme... Read more
Basel, 01 April 2019 Roche’s ipatasertib in combination with Tecentriq and chemotherapy shows promising anti-tumour activity in triple-negative breast cancer in early phase trial Data from Phase Ib study to be presented at American Association for Cancer Research (AACR) 2019 annual congress 73% overall response rate (ORR) irrespective of PD-L1 status or PI3KCA/AKT1/PTEN alteration status... Read more